This common vaccine cuts heart risk nearly in half in new study

sciencedaily - A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications …

AI Summary: New research finds that receipt of a common shingles vaccine is associated with roughly a 50% reduction in serious cardiac events in the studied population. Investigators propose immune‑modulating mechanisms may underlie the protective effect; if confirmed, the vaccine could offer a tidy twofer—preventing shingles and cutting heart risk—proof that prevention sometimes moonlights as cardiology.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

U.S. flu vaccine showed unusually low effectiveness this season / 2 months

Statins Rarely Cause Listed Side Effects, Review Confirms / 3 months

Single‐Shot HPV Vaccine May Suffice to Prevent Cervical Cancer / 5 months

AHA25: Breakthroughs in Cardiovascular and Cardio‐Oncology / 6 months

FDA Greenlights Subcutaneous Daratumumab for Smoldering Multiple Myeloma / 6 months

Intellia CRISPR Trial Fatality Raises Safety Concerns / 6 months

Measles response in vaccine-skeptical California county offers practical playbook / 44 hrs